Medicare Enrolled
Dr. Dilawar Khan, MD
Hematology & Oncology · Rome, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Dilawar Khan is a hematology & oncology specialist in Rome, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 80,089 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khan received a total of $56,869 from 42 pharmaceutical and/or device companies across 159 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 11% volume in GA
$56,869 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗80,089
Medicare services
Top 11% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 27,000 | $43 | $115 |
| Denosumab injection (Prolia/Xgeva) | 12,840 | $18 | $50 |
| Nivolumab injection (Opdivo) | 11,260 | $24 | $100 |
| Anti-nausea injection (aprepitant) | 7,280 | $1 | $5 |
| Paclitaxel chemotherapy injection | 6,348 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,538 | $0 | $8 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,280 | $1 | $79 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,563 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,468 | $7 | $40 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,098 | $10 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
572 | $81 | $158 |
| Injection, leucovorin calcium, per 50 mg | 506 | $3 | $40 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
473 | $2 | $230 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
470 | $2 | $76 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
437 | $87 | $450 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
372 | $10 | $52 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
349 | $11 | $55 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
333 | $9 | $40 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
302 | $19 | $80 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
229 | $6 | $20 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
216 | $73 | $570 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
181 | $42 | $250 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
131 | $15 | $70 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
107 | $13 | $85 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
100 | $41 | $155 |
| PSA test (prostate cancer screening) | 99 | $17 | $85 |
| Iron level test | 97 | $6 | $30 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
97 | $8 | $45 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
95 | $1 | $16 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
92 | $14 | $65 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
90 | $51 | $250 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
87 | $1 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $57 | $107 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
76 | $20 | $110 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
75 | $15 | $55 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
61 | $19 | $100 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
60 | $13 | $50 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
56 | $1 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
55 | $113 | $242 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
53 | $6 | $30 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 52 | $20 | $100 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
52 | $1 | $18 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
42 | $4 | $30 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
40 | $7 | $25 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
40 | $181 | $650 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
39 | $40 | $215 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
38 | $14 | $35 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
35 | $14 | $75 |
| Stool test for hidden blood (FIT) A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method. |
27 | $16 | $45 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $6 | $40 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
20 | $3 | $25 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
19 | $8 | $45 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
15 | $14 | $50 |
| Complete x-ray of body bones An x-ray imaging procedure that captures images of the entire skeletal system. |
11 | $46 | $150 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
11 | $5 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.5% high complexity
90.7% medium
7.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$56,869
Total received (2018-2024)
Avg $8,124/year across 7 years
Top 8% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
159
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,577
2023
$18,725
2022
$12,836
2021
$4,349
2020
$6,413
2019
$2,877
2018
$94
Payments by company (2024)
Eisai Inc.
$4,822
Novocure Inc.
$2,600
AstraZeneca Pharmaceuticals LP
$1,591
Bayer Healthcare Pharmaceuticals Inc.
$1,221
PFIZER INC.
$1,173
Novartis Pharmaceuticals Corporation
$47
ABBVIE INC.
$29
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
GlaxoSmithKline, LLC.
$20
Astellas Pharma US Inc
$19
Regeneron Healthcare Solutions, Inc.
$17
INTUITIVE SURGICAL, INC.
$16
Top 3 companies account for 77.9% of 2024 payments
All-time payments by company (2018-2024) ›
Seagen Inc.
$11,466
AstraZeneca Pharmaceuticals LP
$7,985
Genentech USA, Inc.
$6,946
Eisai Inc.
$4,854
Deciphera Pharmaceuticals Inc.
$4,791
GlaxoSmithKline, LLC.
$4,236
Novartis Pharmaceuticals Corporation
$2,982
Novocure Inc.
$2,600
ABBVIE INC.
$2,476
PFIZER INC.
$1,331
Kite Pharma, Inc.
$1,300
Epizyme, Inc.,
$1,250
Bayer Healthcare Pharmaceuticals Inc.
$1,221
Daiichi Sankyo Inc.
$675
BeiGene USA, Inc.
$525
EMD Serono, Inc.
$500
BeiGene, Ltd.
$450
Janssen Biotech, Inc.
$262
Foundation Medicine, Inc.
$148
Puma Biotechnology, Inc.
$140
Mirati Therapeutics, Inc.
$125
Exelixis Inc.
$96
Astellas Pharma US Inc
$58
Amgen Inc.
$47
Taiho Oncology, Inc.
$46
E.R. Squibb & Sons, L.L.C.
$43
Pharmacyclics LLC, An AbbVie Company
$40
Gilead Sciences, Inc.
$34
EISAI INC.
$26
Merck Sharp & Dohme LLC
$23
US Oncology Corporate, Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Jazz Pharmaceuticals Inc.
$21
Karyopharm Therapeutics Inc.
$19
Merck Sharp & Dohme Corporation
$18
Regeneron Healthcare Solutions, Inc.
$17
INTUITIVE SURGICAL, INC.
$16
Incyte Corporation
$14
Agios Pharmaceuticals, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Seattle Genetics, Inc.
$12
ARRAY BIOPHARMA INC
$6
Top 3 companies account for 46.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Aliqopa · BLENREP · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · Columvi · DARZALEX · Da Vinci Surgical System · ELREXFIO · Enhertu · FOUNDATIONONE · Gazyva · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · NERLYNX · Neulasta · Optune Lua (NovoTTF-200T) · PADCEV · PIQRAY · PLUVICTO · POLIVY · Padcev · QINLOCK · RYBREVANT · SANDOSTATIN · SCEMBLIX · Stivarga · TAGRISSO · TAZVERIK · TECVAYLI · TIBSOVO · TUKYSA · Tepmetko · Trodelvy · VENCLEXTA · VYXEOS · XOSPATA · XPOVIO · YONSA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
6
County median income
$62,540
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH REDMOND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khan is a mixed practice specialist, with above-average Medicare volume (top 11% in GA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Khan performed 27,000 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $56,869 from 42 companies across 159 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other hematology & oncology specialists in Rome?
Dr. Khan's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Rome
Browse hematology & oncology specialists in Rome ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology